4.7 Article

A microfluidic alternating-pull-push active digitization method for sample-loss-free digital PCR

期刊

LAB ON A CHIP
卷 19, 期 24, 页码 4104-4116

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c9lc00932a

关键词

-

资金

  1. KU COBRE Center for Molecular Analysis of Disease Pathways (NIH) [P20GM103638]
  2. National Institutes of Health [R21 CA207816, R21 EB024101, R33 CA214333, R01 CA243445]

向作者/读者索取更多资源

Digital polymerase chain reaction (dPCR) is a powerful tool for genetic analysis, providing superior sensitivity and accuracy. In many applications that demand minuscule reaction volumes, such as single cell analysis, efficient and reproducible sample handling and digitization is pivotal for accurate absolute quantification of targets, but remains a significant technical challenge. In this paper, we described a robust and flexible microfluidic alternating-pull-push active digitization (mu APPAD) strategy that confers close to 100% sample digitization efficiency for microwell-based dPCR. Our strategy employs pneumatic valve control to periodically manipulate air pressure inside the chip to greatly facilitate the vacuum-driven partition of solution into microwells, enabling efficient digitization of a small-volume solution with significantly reduced volume variability. The mu APPAD method was evaluated on both tandem-channel and parallel-channel chips, which achieved a digitization efficiency of 99.5 +/- 0.3% and 94.6 +/- 0.9% within 10.5 min and 2 min, respectively. To assess the analytical performance of the mu APPAD chip, we calibrated it for absolution dPCR quantitation of lambda DNA across a range of concentrations. The results obtained with our chip matched well with the theoretical curve computed from Poisson statistics. Compared to the existing methods for highly efficient sample digitization, not only does our technology greatly reduce the constraints on microwell geometries and channel design, but also benefits from the intrinsic amenability of the pneumatic valve technique with device integration and automation. Thus we envision that the mu APPAD technology will provide a scalable and widely adaptable platform to promote the development of advanced lab-on-a-chip systems integrating microscale sample processing with dPCR for a broad scope of applications, such as single cell analysis of tumor heterogeneity and genetic profiling of circulating exosomes directly in clinical samples.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据